Results 111 to 120 of about 1,267,582 (207)
Background: Opioid dependence is a critical public health issue in Northeast India, with limited data available on the affected population. Aim: This study examines the sociodemographic and clinical profiles of opioid-dependent individuals in Assam ...
Pranjal J. Chakravarty +4 more
doaj +1 more source
Transcriptomic Profiling of SLC and ABC Transporters in the Human Term Placenta
Solute carriers (SLC) and ATP‐binding cassette (ABC) transporters are essential for placental solute exchange and fetal protection, yet their transcriptomic profiles in the human placenta remain poorly characterized. Although fetal sex influences placental development and function, its impact on transporter expression is unclear.
Elijah Marsh Jung +12 more
wiley +1 more source
Opioids, while highly effective for pain management, are among the most addictive substances, contributing significantly to the global opioid crisis.
Michael Swingler +4 more
doaj +1 more source
Although sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are recommended for patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), concerns regarding urogenital infections persist. Therefore, we evaluated the risk of urinary tract infection (UTI) and genital tract infection (GTI) after SGLT2i initiation in this population ...
Young‐Mi Ah +4 more
wiley +1 more source
CYP2D6‐Guided Opioid Therapy for Chronic Pain: A Multi‐Center Pragmatic Randomized Controlled Trial
The analgesic effectiveness of several opioids depends on CYP2D6‐mediated metabolism to more active opioid receptor agonists. CYP2D6 activity is impacted by genetic variability and medications that inhibit CYP2D6. We conducted a pragmatic, multi‐center, randomized, controlled trial to determine whether CYP2D6‐guided opioid prescribing improves chronic ...
Todd C. Skaar +255 more
wiley +1 more source
Advancing Precision Therapeutics in Older Adults: A Scoping Review of Pharmacogenomic Service Models
Older adults remain a therapeutically understudied population despite experiencing the highest burden of polypharmacy, age‐related pharmacokinetic and pharmacodynamic variability, and medication‐related harm. Pharmacogenomic testing offers an opportunity to individualize drug therapy in this population; however, its clinical implementation is ...
Eman Wehbe +5 more
wiley +1 more source
Post‐mortem blood drug concentrations exhibit substantial overlap between deaths in which a drug was implicated and those in which it was not. Analysis of over 58,000 NPSUM cases demonstrates that demographic stratification does not resolve this uncertainty, reinforcing the need for contextual, evidence‐based interpretation rather than concentration ...
Thikra Algahtani +6 more
wiley +1 more source
Tapentadol as a drug of abuse – A preliminary report
Background: Tapentadol is a dual action opioid analgesic with emerging data on abuse and diversion. Aim: This study describes tapentadol abuse, clinical presentation, and treatment patterns.
Prakrithi Shivaprakash +7 more
doaj +1 more source
ABSTRACT Objective Psychotherapy is the first‐line treatment for eating disorders (EDs), yet only about half of patients benefit long‐term. Bulimia nervosa (BN), Binge‐Eating‐Disorder (BED), and non‐underweight EDs with regular binge eating (> 2 binge‐eating episodes per month within the last 3 months) (OSFED/UFED) form a transdiagnostic group ...
Sebastian M. Max +7 more
wiley +1 more source
Treatment of Opioid Dependence and Overdose
Every day in America, 90 individuals die from overdosing on prescription pain relievers or synthetic opioids. From 1999 to 2015, American deaths from opioid drug overdoses increased from 8,048 to 33,091 (National Institute on Drug Abuse, 2017 ...
Jessi Jeffries (10079821)
core +1 more source

